Clinical Trial: A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy

U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07493057) titled 'A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy' on March 20.

Brief Summary: This study is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase III clinical trial evaluating the efficacy and safety of GZR18 injection in obese subjects with moderate to severe obstructive sleep apnea who are unable or unwilling to undergo positive airway pressure (PAP) therapy.

Study Start Date: April 27

Study Type: INTERVENTIONAL

Condition: Obstructive Sleep Apnea (OSA)

Intervention: DR...